Guo-Ping Yang (Guoping Yang)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 46

Top Topics

Atrial Fibrillation

St Segment Elevation Myocardial Infarction

Top Venues

Drug design, development and therapy

Antimicrobial agents and chemotherapy

Pharmaceuticals (Basel, Switzerland)

Clinical drug investigation

This page only lists publications with an associated author ORCID identifier.

Publications

Yuncheng Ni, Ranglang Huang, Shuang Yang, Xiao Yan Yang, Shan Zeng, An Yao, Jie Huang, Guo-Ping Yang
Pharmacokinetics and Safety of Oliceridine Fumarate Injection in Chinese Patients with Chronic Non-Cancer Pain: A Phase I, Single-Ascending-Dose, Open-Label Clinical Trial. Drug design, development and therapy 18 (2024)
Shanshan Nie, Yuhang Zhao, Zeying Feng, Chan Zou, Fangfang Ding, Liying Gong, Hongwei Lu, Yu Cao, Guo-Ping Yang
Effect of Ticagrelor versus Clopidogrel on All-Cause and Cardiovascular Mortality in Acute Coronary Syndrome Patients with Hyperuricemia. Clinical drug investigation (2024)
Xin Yan, Yuanyuan Huang, Jinlian Xie, Qian Wu, Shuang Yang, Xiaoyan Yang, Honghui Chen, Jie Huang, Guo-Ping Yang
Safety, tolerability, and pharmacokinetics of HRS9432(A) injection in healthy Chinese subjects: a phase-I randomized, double-blind, dose escalation, placebo-controlled study. Antimicrobial agents and chemotherapy 68 (7) (2024)
Yuncheng Ni, Ranglang Huang, Shuang Yang, Xiao Yan Yang, Shan Zeng, An Yao, Jie Huang, Guo-Ping Yang
Pharmacokinetics and Safety of Oliceridine Fumarate Injection in Chinese Patients with Chronic Non-Cancer Pain: A Phase I, Single-Ascending-Dose, Open-Label Clinical Trial. Drug design, development and therapy 18 (2024)
Junlong Ma, Yaxin Liu, Yuanyuan Sun, Chengxian Guo, Guo-Ping Yang
Increased Pneumonia Risk Associated with Concomitant Use of Inhaled Corticosteroids and Benzodiazepines: A Pharmacovigilance Analysis. Lung (2024)
Jinfu Peng, Jie Huang, Hongyi Tan, Yun Kuang, Guo-Ping Yang, Zhijun Huang
Model-Informed Dose Selection for a Novel Human Immunoglobulin G4 Derived Monoclonal Antibody Targeting Proprotein Convertase Kwashiorkor Type 9: Insights from Population Pharmacokinetics-Pharmacodynamics and Systems Pharmacology. ACS pharmacology & translational science 7 (2) (2024)
Yuan Li, Meilin Zhang, Shengnan Zhang, Guo-Ping Yang
Promising Effects of Montelukast for Critically Ill Asthma Patients via a Reduction in Delirium. Pharmaceuticals (Basel, Switzerland) 17 (1) (2024)
Jinfu Peng, Jie Huang, Hongyi Tan, Yun Kuang, Guo-Ping Yang, Zhijun Huang
Model-Informed Dose Selection for a Novel Human Immunoglobulin G4 Derived Monoclonal Antibody Targeting Proprotein Convertase Kwashiorkor Type 9: Insights from Population Pharmacokinetics-Pharmacodynamics and Systems Pharmacology. ACS pharmacology & translational science 7 (2) (2024)
Yuan Li, Meilin Zhang, Shengnan Zhang, Guo-Ping Yang
Promising Effects of Montelukast for Critically Ill Asthma Patients via a Reduction in Delirium. Pharmaceuticals (Basel, Switzerland) 17 (1) (2024)
Xin Yan, Yuanyuan Huang, Jinlian Xie, Qian Wu, Shuang Yang, Xiaoyan Yang, Honghui Chen, Jie Huang, Guo-Ping Yang
Safety, tolerability, and pharmacokinetics of HRS9432(A) injection in healthy Chinese subjects: a phase-I randomized, double-blind, dose escalation, placebo-controlled study. Antimicrobial agents and chemotherapy 68 (7) (2024)
Shanshan Nie, Yuhang Zhao, Zeying Feng, Chan Zou, Fangfang Ding, Liying Gong, Hongwei Lu, Yu Cao, Guo-Ping Yang
Effect of Ticagrelor versus Clopidogrel on All-Cause and Cardiovascular Mortality in Acute Coronary Syndrome Patients with Hyperuricemia. Clinical drug investigation 44 (3) (2024)
Xin Yan, Yuanyuan Huang, Jinlian Xie, Qian Wu, Shuang Yang, Xiaoyan Yang, Honghui Chen, Jie Huang, Guo-Ping Yang
Safety, tolerability, and pharmacokinetics of HRS9432(A) injection in healthy Chinese subjects: a phase-I randomized, double-blind, dose escalation, placebo-controlled study. Antimicrobial agents and chemotherapy (2024)
Shanshan Nie, Yuhang Zhao, Zeying Feng, Chan Zou, Fangfang Ding, Liying Gong, Hongwei Lu, Yu Cao, Guo-Ping Yang
Effect of Ticagrelor versus Clopidogrel on All-Cause and Cardiovascular Mortality in Acute Coronary Syndrome Patients with Hyperuricemia. Clinical drug investigation 44 (3) (2024)
Yuan Li, Meilin Zhang, Shengnan Zhang, Guo-Ping Yang
Promising Effects of Montelukast for Critically Ill Asthma Patients via a Reduction in Delirium. Pharmaceuticals (Basel, Switzerland) 17 (1) (2024)
Xin Yan, Yuanyuan Huang, Jinlian Xie, Qian Wu, Shuang Yang, Xiaoyan Yang, Honghui Chen, Jie Huang, Guo-Ping Yang
Safety, tolerability, and pharmacokinetics of HRS9432(A) injection in healthy Chinese subjects: a phase-I randomized, double-blind, dose escalation, placebo-controlled study. Antimicrobial agents and chemotherapy 68 (7) (2024)
Xin Yan, Yuanyuan Huang, Jinlian Xie, Qian Wu, Shuang Yang, Xiaoyan Yang, Honghui Chen, Jie Huang, Guo-Ping Yang
Safety, tolerability, and pharmacokinetics of HRS9432(A) injection in healthy Chinese subjects: a phase-I randomized, double-blind, dose escalation, placebo-controlled study. Antimicrobial agents and chemotherapy 68 (7) (2024)
Long Song, Yuan Li, Shanshan Nie, Zeying Feng, Yaxin Liu, Fangfang Ding, Liying Gong, Liming Liu, Guo-Ping Yang
Using machine learning to predict adverse events in acute coronary syndrome: A retrospective study. Clinical cardiology (2023)
Yaxin Liu, Yun Kuang, Min Hai, Dongyang Liu, Dongyang Liu, Guo-Ping Yang
Model-Informed Dosing Regimen of Ticagrelor in Chinese Patients with Acute Coronary Syndrome. Clinical pharmacology and therapeutics (2023)
Xin Huang, Biwen Hu, Ling Ye, Tong Li, Li He, Wei Tan, Guo-Ping Yang, Jun-Ping Liu, Cheng-Xian Guo
Pharmacogenomics and adverse effects of anti-infective drugs in children. Clinical and experimental pharmacology & physiology (2023)
Cui Tang, Hui Wang, Lina Guo, Chan Zou, Jianming Hu, Hanyong Zhang, Wenhu Zhou, Guo-Ping Yang
CpG-Conjugated Silver Nanoparticles as a Multifunctional Nanomedicine to Promote Macrophage Efferocytosis and Repolarization for Atherosclerosis Therapy. ACS applied materials & interfaces (2023)
Xiaoyan Huang, Yi Xiao, Danrong Jing, Yuzhou Huang, Songchun Yang, Zhijun Huang, Guo-Ping Yang, Yanying Duan, Meian He, Juan Su, Mingliang Chen, Xiang Chen, Minxue Shen
Arsenic exposure and pruritus: Evidence from observational, interventional, and mendelian randomization studies. Allergy (2023)
Junlong Ma, Jie Huang, Chan Zou, Qian Wu, Jinlian Xie, Xingfei Zhang, Xiaoyan Yang, Shuang Yang, Ziteng Wu, Yan Jiang, Sen Yu, Xuqing Zhang, Guo-Ping Yang, Mingyuan Li
A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Novel Intravenous Formulation of Meloxicam (QP001) in Healthy Chinese Subjects. Drug design, development and therapy 17 (2023)
Fangfang Ding, Jie Huang, Zeying Feng, Yun Kuang, Shuang Yang, Yuxia Xiang, Chan Zou, Guo-Ping Yang
A pharmacokinetic study to comparatively evaluate the bioequivalence and safety of a humanized recombinant monoclonal antibody targeting human epidermal growth factor receptor-2 with the reference Herceptin in healthy Chinese subjects. Investigational new drugs 40 (3) (2022)
Zeying Feng, Yaxin Liu, Yun Kuang, Shuang Yang, Jinlei Li, Ling Ye, Jie Huang, Qi Pei, Yuanyuan Huang, Guo-Ping Yang
Open-Label, Phase I, Pharmacokinetic Studies in Healthy Chinese Subjects to Evaluate the Bioequivalence and Food Effect of a Novel Formulation of Abiraterone Acetate Tablets. Drug design, development and therapy 16 (2022)
Kunhong Deng, Yi Zou, Chan Zou, Hong Wang, Yuxia Xiang, Xiaoyan Yang, Shuang Yang, Chang Cui, Guo-Ping Yang, Jie Huang
Study on pharmacokinetic interactions between SHR2554 and itraconazole in healthy subjects: A single-center, open-label phase I trial. Cancer medicine (2022)
Siyi Wang, Xiaoyan Yang, Jie Huang, Shuang Yang, Qian Wu, Honghui Chen, Shuting Wu, Changlin Dou, Guo-Ping Yang, Yuxia Xiang
Pharmacokinetics, pharmacodynamics, safety, and immunogenicity of a biosimilar of denosumab (LY06006): a randomized, double-blind, single-dose, parallel-controlled clinical study in healthy Chinese subjects. Expert opinion on investigational drugs 31 (10) (2022)
Kaifeng Chen, Ping Luo, Guo-Ping Yang, Shaihong Zhu, Chenhui Deng, Junjie Ding, Yaqi Lin, Liyong Zhu, Qi Pei
Population pharmacokinetics of omeprazole in obese and normal-weight adults. Expert review of clinical pharmacology 15 (4) (2022)
Chengxiao Fu, Qi Pei, Wu Liang, Bo Yang, Wei Li, Jun Liu, Hongyi Tan, Cheng-Xian Guo, Hao Zhang, Guo-Ping Yang
Population Pharmacokinetic Modelling for Nifedipine to Evaluate the Effect of Parathyroid Hormone on CYP3A in Patients with Chronic Kidney Disease. Drug design, development and therapy 16 (2022)
Tong Li, Biwen Hu, Ling Ye, Zeying Feng, Longjian Huang, Chengjun Guo, Xiong Wu, Wei Tan, Yi Wang, Guo-Ping Yang, Cheng-Xian Guo
Clinically Significant Cytochrome P450-Mediated Drug-Drug Interactions in Children Admitted to Intensive Care Units. International journal of clinical practice 2022 (2022)
Hui Wang, Jie Huang, Shuang Yang, Xing-Fei Zhang, Xiaoyan Yang, Chang Cui, Chan Zou, Li-E Li, Min Zhang, Miao-Fu Mao, Xiang Zhou, Kai-Ming Duan, Sai-Ying Wang, Guo-Ping Yang
Bioavailability and Safety of a New Highly Concentrated Midazolam Nasal Spray Compared to Buccal and Intravenous Midazolam Treatment in Chinese Healthy Volunteers. Neurology and therapy 11 (2) (2022)
Chan Zou, Jordan A Beard, Guo-Ping Yang, William E Evans, Erik J Bonten
CASP orter: A Novel Inducible Human CASP1/NALP3/ASC Inflammasome Biosensor. Journal of inflammation research 15 (2022)
Meng-Na Wang, Hai-Tao Yu, Ya-Qian Li, Yun Zeng, Shuang Yang, Guo-Ping Yang, Qi Pei, Jie Huang
Bioequivalence and Pharmacokinetic Profiles of Generic and Branded Obeticholic Acid in Healthy Chinese Subjects Under Fasting and Fed Conditions. Drug design, development and therapy 15 (2021)
Kaifeng Chen, Yaqi Lin, Ping Luo, Nan Yang, Guo-Ping Yang, Liyong Zhu, Qi Pei
Effect of laparoscopic sleeve gastrectomy on drug pharmacokinetics. Expert review of clinical pharmacology (2021)
Meng-Na Wang, Yun Kuang, Li-Ying Gong, Ye Hua, Qi Pei, Cheng-Xian Guo, Yu Cao, Jie Huang, Guo-Ping Yang
First-in-human, phase I single-ascending-dose study of the safety, pharmacokinetics, and relative bioavailability of selatinib, a dual EGFR-ErbB2 inhibitor in healthy subjects. Investigational new drugs 38 (6) (2020)
Yun Zeng, Jie Huang, Chang Cui, Shuang Yang, Ze-Yu Zhang, Saqib Ali, Zhi-Jun Huang, Guo-Ping Yang
QL0902, a proposed etanercept biosimilar: pharmacokinetic and immunogenicity profile to its reference product in healthy Chinese male subjects. Expert opinion on biological therapy 21 (1) (2020)
Yaqian Li, Jingjing Yu, Yun Kuang, Chengkun Wu, Liu Yang, Qiulian Fang, Qi Pei, Guo-Ping Yang
Quality of oral anticoagulation control in Chinese patients with non-valvular atrial fibrillation: a prospective controlled study. Current medical research and opinion 36 (9) (2020)
Li He, Shaojun Chen, Jingao Li, Xiaoxue Xie, Lihua Huang, Yun Kuang, Kangwei Xu, Wanxia Huang, Yanling Zhao, Guo-Ping Yang, Cheng-Xian Guo
Genetic and phenotypic frequency distribution of CYP2C9, CYP2C19 and CYP2D6 in over 3200 Han Chinese. Clinical and experimental pharmacology & physiology 47 (10) (2020)
Jie Huang, Wen-Yu Liu, Jing-Jing Yu, Jin-Bo Yang, Min Li, Chan Zou, Cheng-Xian Guo, Xiao-Yan Yang, Shuang Yang, Jin-Lian Xie, Zhi-Jun Huang, Hui Chen, Qi Pei, Guo-Ping Yang
Exploration of suitable pharmacodynamic parameters for acarbose bioequivalence evaluation: A series of clinical trials with branded acarbose. British journal of clinical pharmacology 86 (11) (2020)
Qi Pei, Jin-Lian Xie, Hao Zhang, Guo-Ping Yang
Response by Pei et al. to letters regarding article, "Pharmacokinetic study of imrecoxib in patients with renal insufficiency". European journal of clinical pharmacology 76 (3) (2020)
Yun Kuang, Hui-Ling Song, Guo-Ping Yang, Qi Pei, Xiao-Yan Yang, Ling Ye, Shuang Yang, Shu-Ting Wu, Can Guo, Qing-Nan He, Jie Huang
Effect of high-fat diet on the pharmacokinetics and safety of flumatinib in healthy Chinese subjects. Cancer chemotherapy and pharmacology 86 (3) (2020)
Ya-Nan Liu, Jie Huang, Can Guo, Shuang Yang, Ling Ye, Shu-Ting Wu, Xing-Fei Zhang, Xiao-Yan Yang, Cui-Cui Han, Qi Pei, Lu Huang, Qing-Nan He, Guo-Ping Yang
A randomized, double-blind, single-dose study to evaluate the biosimilarity of QL1101 with bevacizumab in healthy male subjects. Cancer chemotherapy and pharmacology 85 (3) (2020)
Xiaoyi Ning, Yun Kuang, Shuwei Zhao, Wenjing Hou, Guo-Ping Yang, Xuerui Zhu, Ruiling Liu, Jie Huang
Design of an Optimally-Diagnostic Skin Test for Diagnosis of Sensitivity to Eight Allergens: A First-in-Human Study of Dose Escalation and Simultaneous Administration in Chinese Subjects. Journal of asthma and allergy 13 (2020)
Shanshan Nie, Guo-Ping Yang, Hongwei Lu
Current Molecular Targeted Agents for Advanced Gastric Cancer. OncoTargets and therapy 13 (2020)
Qi Pei, Jin-Lian Xie, Jie Huang, Wen-Yu Liu, Xiao-Yan Yang, Yan Wang, Wei Li, Hong-Yi Tan, Hao Zhang, Guo-Ping Yang
Pharmacokinetic study of imrecoxib in patients with renal insufficiency. European journal of clinical pharmacology 75 (10) (2019)
Jianwen Wang, Jie Huang, Wei Li, Shiqi Tang, Jian Sun, Xianming Zhang, Jun Liu, Bin Yi, Jishi Liu, Xingfei Zhang, Qian Yang, Xiaoyan Yang, Shuang Yang, Guo-Ping Yang, Hao Zhang
Polyethylene glycol loxenatide (PEX168) in subjects with renal impairment: A pharmacokinetic study. British journal of clinical pharmacology 85 (12) (2019)
Jing Wang, Jie Huang, Shuang Yang, Chang Cui, Ling Ye, Sai-Ying Wang, Guo-Ping Yang, Qi Pei
Pharmacokinetics and Safety of Esketamine in Chinese Patients Undergoing Painless Gastroscopy in Comparison with Ketamine: A Randomized, Open-Label Clinical Study. Drug design, development and therapy 13 (2019)